Log in
Enquire now
‌

US Patent 10160742 Pyridyl reverse sulfonamides for HBV treatment

Patent 10160742 was granted and assigned to Novira Therapeutics on December, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Novira Therapeutics
Novira Therapeutics
0
Current Assignee
Novira Therapeutics
Novira Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101607420
Patent Inventor Names
Yen Truong0
Jason Jacintho0
Nicholas Stock0
Ryan C. Clark0
Date of Patent
December 25, 2018
0
Patent Application Number
156762360
Date Filed
August 14, 2017
0
Patent Citations Received
‌
US Patent 10428041 Pyridyl reverse sulfonamides for HBV treatment
0
Patent Primary Examiner
‌
Daniel R Carcanague
0
Patent abstract

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10160742 Pyridyl reverse sulfonamides for HBV treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.